IMUNON, Inc. (Nasdaq: IMNN) Announces Stock Split and Dividend Amid Phase 3 Clinical Trials
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameImunon, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









